Meningitis and Encephalomyelitis in Horses

Veterinary Clinics of North America - Equine Practice

Volumn 22, Issue 2, 2006, Pages 553-589

  Pellegrini Masini, Alessandra ^a   Livesey, Leanda C ^b  

^a Physiol and Pharmacol   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; ENCEPHALOMYELITIS; HORSE; HORSE DISEASE; MENINGITIS; MICROBIOLOGY; PARASITOLOGY; REVIEW; VIRUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ENCEPHALOMYELITIS; ENCEPHALOMYELITIS, EQUINE; HORSE DISEASES; HORSES; MENINGITIS; WEST NILE FEVER;

EQUIDAE; EQUUS CABALLUS;

EID: 33746365160     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2006.03.003     Document Type: Review

References (193)

1. Snyder R.D. Bacterial meningitis: diagnosis and treatment. Curr Neurol Neurosci Rep 3 (2003) 461-469
2. Santschi E.M., and Foreman J.H. Equine bacterial meningitis-part I. Compend Contin Educ Pract Vet 11 (1989) 479-483
3. Morris D.D., and Rutkowski J. Therapy in two cases of neonatal foal septicaemia and meningitis with cefotaxime sodium. Equine Vet J 19 (1987) 151-154
4. Platt H. Septicaemia in the foal. A review of 61 cases. Br Vet J 129 (1973) 221-229
5. Stuart B.P., Martin B.R., Williams Jr. L.P., et al. Salmonella-induced meningoencephalitis in a foal. J Am Vet Med Assoc 162 (1973) 211-213
6. Rush Moore B. Bacterial meningitis in foals. Compend Contin Educ Pract Vet 17 (1995) 1417-1420
7. Tyler C.M., Davis R.E., Begg A.P., et al. A survey of neurological diseases in horses. Aust Vet J 70 (1993) 445-449
8. Adams R., and Mayhew I.G. Neurologic diseases. Vet Clin North Am Equine Pract 1 (1985) 209-234
9. Barklay W.P., and deLahunta A. Cryptococcal meningitis in a horse. J Am Vet Med Assoc 174 (1979) 1236-1238
10. Steckel R.R., Adams S.B., Long G.G., et al. Antemortem diagnosis and treatment of cryptococcal meningitis in a horse. J Am Vet Med Assoc 180 (1982) 1085-1089
11. Barton M.D., and Knight I. Cryptococcal meningitis of a horse. Aust Vet J 48 (1972) 534
12. Smith J.J., Provost P.J., and Paradis M.R. Bacterial meningitis and brain abscesses secondary to infectious disease processes involving the head in horses: seven cases (1980-2001). J Am Vet Med Assoc 224 (2004) 739-742
13. Ford J., and Lokai M.D. Complications of Streptococcus equi infection. Equine Pract 2 (1980) 41-44
14. Allen J.R., Barbee D.D., Boulton C.R., et al. Brain abscess in a horse: diagnosis by computed tomography and successful surgical treatment. Equine Vet J 19 (1987) 552-555
15. Cornelisse C.J., Schott II H.C., Lowrie C.T., et al. Successful treatment of intracranial abscesses in 2 horses. J Vet Intern Med 15 (2001) 494-500
16. Foreman J.H., and Santschi E.M. Equine bacterial meningitis-part II. Compend Contin Educ Pract Vet 11 (1989) 640-644
17. Raphael C.F. Brain abscess in three horses. J Am Vet Med Assoc 180 (1973) 874-877
18. Devriese L.A., Sustronck B., Maenhout T., et al. Streptococcus suis meningitis in a horse. Vet Rec 21 (1990) 68
19. Rumbaugh G.E. Disseminated meningitis in a mare. J Am Vet Med Assoc 171 (1977) 452-454
20. Timoney P.J., McArdle J.F., and Bryne M.J. Abortion and meningitis in a Thoroughbred mare associated with Klebsiella pneumoniae, type 1. Equine Vet J 15 (1983) 64-65
21. Reilly L., Habecker P., Beech J., et al. Pituitary abscess and basilar empyema in 4 horses. Equine Vet J 26 (1994) 424-426
22. Tietje S., Becker M., and Bockenhoff G. Computed tomographic evaluation of head diseases in the horse: 15 cases. Equine Vet J 28 (1996) 98-105
23. Brass D.A. Pathophysiology and neuroimmunology of bacterial meningitis. Compend Contin Educ Pract Vet 16 (1994) 45-53
24. Newton S.A. Suspected bacterial meningoencephalitis in two adult horses. Vet Rec 142 (1998) 665-669
25. Pellegrini-Masini A., Bentz A.I., Johns I.C., et al. Common variable immunodeficiency in three horses with presumptive bacterial meningitis. J Am Vet Med Assoc 227 (2005) 114-122
26. Hussein A.S., and Shafran S.D. Acute bacterial meningitis in adults: a 12-year review. Medicine (Baltimore) 79 (2000) 360-368
27. Tunbridge A., and Read R.C. Management of meningitis. Clin Med 4 (2004) 499-505
28. Coant P.N., Kornberg A.E., Duffy L.C., et al. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care 8 (1992) 200-205
29. Seehusen D.A., Reeves M.M., and Fomin D.A. Cerebrospinal fluid analysis. Am Fam Physician 68 (2003) 1103-1108
30. Araj G.F., Hamati A.I., Sinno D.D., et al. Bacterial meningitis with normal cerebrospinal fluid findings. Report of a case and review of the literature. J Med Liban 41 (1993) 86-89
31. Rebeu-Dartiguelongue I., Laurent J.P., Clarac A., et al. Early lumbar puncture and cutaneous rash: a clear CSF is not always a normal CSF. Med Mal Infect 35 (2005) 422-424
32. Furr M.O., and Bender H. Cerebrospinal fluid variables in clinically normal foals from birth to 42 days of age. Am J Vet Res 55 (1994) 781-784
33. Quagliarello V.J., and Scheld W.M. Treatment of bacterial meningitis. N Engl J Med 336 (1997) 708-716
34. Sinner S.W., and Tunkel A.R. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am 18 (2004) 581-602
35. Dowling P.M. Clinical pharmacology of nervous system diseases. Vet Clin North Am Equine Pract 15 (1999) 575-588
36. Brewer B.D. Therapeutic strategies involving antimicrobial treatment of the central nervous system in large animals. J Am Vet Med Assoc 185 (1984) 1217-1221
37. Rahal J.J., and Simberkoff M.S. Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob Agents Chemother 16 (1979) 13-18
38. Garvey G. Current concepts of bacterial infections of the central nervous system. J Neurosurg 59 (1983) 735-744
39. Pankey G.A., and Sabath L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections. Clin Infect Dis 38 (2004) 864-870
40. Tauber M.G., Doroshow C.A., Hackbarth C.J., et al. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis 149 (1984) 568-574
41. Prasad K., Singhal T., Jain N., et al. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev 2 (2004) CD001832
42. Ringger N.C., Pearson E.G., Gronwall R., et al. Pharmacokinetics of ceftriaxone in healthy horses. Equine Vet J 28 (1996) 476-479
43. Carrillo N.A., Giguere S., Gronwall R.R., et al. Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses. Am J Vet Res 66 (2005) 30-35
44. Cervantes C.C., Brown M.P., Gronwall R., et al. Pharmacokinetics and concentrations of ceftiofur sodium in body fluids and endometrium after repeated intramuscular injections in mares. Am J Vet Res 54 (1993) 573-575
45. Ringger N.C., Browns M.P., Kohlepp S.J., et al. Pharmacokinetics of ceftriaxone in neonatal foals. Equine Vet J 30 (1998) 163-165
46. Gardner S.Y., Sweeney R.W., and Divers T.J. Pharmacokinetics of cefotaxime in neonatal pony foals. Am J Vet Res 54 (1993) 576-579
47. Meyer J.C., Brown M.P., Gronwall R.R., et al. Pharmacokinetics of ceftiofur sodium in neonatal foals after intramuscular injection. Equine Vet J 24 (1992) 485-486
48. Guglick M.A., MacAllister C.G., Clarke C.R., et al. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses. Am J Vet Res 59 (1998) 458-463
49. Scheld W.M., and Sande M.A. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest 71 (1983) 411-419
50. Regodon S., Franco A., Lignereux Y., et al. A new technique for accessing the cerebral ventricles of the horse. Res Vet Sci 55 (1993) 389-391
51. Shah S., Ohlsson A., and Shah V. Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev 4 (2004) CD004496
52. Scheld W.M., Koedel U., Nathan B., et al. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 186 Suppl (2002) S225-S233
53. Nau R., and Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25 (2002) 38-45
54. Nau R., and Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 15 (2002) 95-110
55. Townsend G.C., and Scheld W.M. The use of corticosteroids in the management of bacterial meningitis in adults. J Antimicrob Chemother 37 (1996) 1051-1061
56. Chaudhuri A. Adjunctive dexamethasone treatment in acute bacterial meningitis. Lancet Neurol 3 (2004) 54-62
57. van de Beek D., de Gans J., McIntyre P., et al. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 4 (2004) 139-143
58. Gomes J.A., Stevens R.D., Lewin III J.J., et al. Glucocorticoid therapy in neurologic critical care. Crit Care Med 33 (2005) 1214-1224
59. Pile J.C., and Longworth D.L. Should adults with suspected acute bacterial meningitis get adjunctive corticosteroids?. Cleve Clin J Med 72 (2005) 67-70
60. van de Beek D., de Gans J., McIntyre P., et al. Review: adjuvant corticosteroid therapy reduces death, hearing loss, and neurological sequelae in bacterial meningitis. Cochrane Database Syst Rev 3 (2003) CD004305
61. Bonadio W.A. Adjunctive dexamethasone therapy for pediatric bacterial meningitis. J Emerg Med 14 (1996) 165-172
62. Feigin R.D. Use of corticosteroids in bacterial meningitis. Pediatr Infect Dis J 23 (2004) 355-357
63. Irazuzta J., Pretzlaff R.K., and deCourten-Myers G. Dexamethasone decreases neurological sequelae and caspase activity. Intensive Care Med 31 (2005) 146-150
64. Gupta S., and Tuladhar A.B. Does early administration of dexamethasone improve neurological outcome in children with meningococcal meningitis?. Arch Dis Chil 89 (2004) 82-83
65. Meli D.N., Loeffler J.M., Baumann P., et al. In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol 151 (2004) 6-11
66. Leib S.L., Leppert D., Clements J., et al. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 68 (2000) 615-620
67. Pfister L.A., Tureen J.H., Shaw S., et al. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meninigitis. Ann Neurol 47 (2000) 329-335
68. Pfister H.W., and Scheld W.M. Brain injury in bacterial meningitis: therapeutic implications. Curr Opin Neurol 10 (1997) 254-259
69. Brandt C.T., Lundgren J.D., Frimodt-Moller N., et al. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis. J Neuroimmunol 166 (2005) 126-131
70. Park W.S., Chang Y.S., and Lee M. The efficacy of pentoxifylline as an anti-inflammatory agent in experimental Escherichia coli meningitis in the newborn piglet. Biol Neonate 77 (2000) 236-242
71. Lindvall P., Ahlm C., Ericsson M., et al. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 38 (2004) 384-390
72. Moore R.M., and Trims C.M. Effect of xylazine on intracranial pressure in conscious horses. [abstract]. Vet Surg 20 (1991) 155-156
73. Moore R.M., and Trims C.M. Effect of xylazine on cerebrospinal fluid pressure in conscious horses. Am J Vet Res 53 (1992) 1558-1561
74. Natalini C.C., and Robinson E.P. Effects of lumbosacral subarachnoid catheterization in horses. Vet Surg 28 (1999) 525-528
75. Lorenzl S., Koedel U., and Pfister H.W. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Crit Care Med 24 (1996) 1874-1880
76. Murthy J.M. Management of intracranial pressure in tuberculous meningitis. Neurocrit Care 2 (2005) 306-312
77. Grande P.O., Myhre E.B., Nordstrom C.H., et al. Treatment of intracranial hypertension and aspects on lumbar dural puncture in severe bacterial meningitis. Acta Anaesthesiol Scand 46 (2002) 264-270
78. Patel S., Lederman E., and Wallace M. Acetazolamide therapy and intracranial pressure. Clin Infect Dis 36 (2003) 538
79. MacKay R.J., Granstrom D.E., Saville W.J., et al. Equine protozoal myeloencephalitis. Vet Clin North Am Equine Pract 16 (2000) 405-425
80. Dubey J.P., Lindsay D.S., Saville W.J., et al. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM). Vet Parasitol 95 (2001) 89-131
81. Furr M., MacKay R., Granstrom D., et al. Clinical diagnosis of equine protozoal myeloencephalitis (EPM). J Vet Intern Med 16 (2002) 618-621
82. Daft B.M., Barr B.C., Gardner I.A., et al. Sensitivity and specificity of Western blot testing of cerebrospinal fluid and serum for diagnosis of equine protozoal myeloencephalitis in horses with and without neurologic abnormalities. J Am Vet Med Assoc 221 (2002) 1007-1013
83. Furr M. Antigen-specific antibodies in cerebrospinal fluid after intramuscular injection of ovalbumin in a horse. J Vet Intern Med 16 (2002) 588-592
84. Witonsky S., Morrow J.K., Leger C., et al. Sarcocystis neurona-specific immunoglobulin G in the serum and cerebrospinal fluid of horses administered S neurona vaccine. J Vet Intern Med 18 (2004) 98-103
85. Miller M.M., Sweeney C.R., Russel G.E., et al. Effects of blood contamination of cerebrospinal fluid on Western blot analysis for detection of antibodies against Sarcocystis neurona and on albumin quotient and immunoglobulin G index in horses. J Am Vet Med Assoc 215 (1999) 67-71
86. Tipold A. Cerebrospinal fluid. In: Braund K.G. (Ed). Clinical neurology in small animals: localization, diagnosis and treatment (2003), International Veterinary Information Service, Ithaca (NY). B0235.0803. Available at: www.ivis.org
87. Rossano M.G., Kaneene J.B., Schott II H.C., et al. Assessing the agreement of Western blot test results for paired serum and cerebrospinal fluid samples from horses tested for antibodies to Sarcocystis neurona. Vet Parasitol 115 (2003) 233-238
88. Lindsay D.S., and Dubey J.P. Direct agglutination test for the detection of antibodies to Sarcocystis neurona in experimentally infected animals. Vet Parasitol 95 (2001) 179-186
89. Duarte P.C., Daft B.M., Conrad P.A., et al. Comparison of a serum indirect fluorescent antibody test with two Western blot tests for the diagnosis of equine protozoal myeloencephalitis. J Vet Diagn Invest 15 (2003) 8-13
90. Duarte P.C., Daft B.M., Conrad P.A., et al. Evaluation and comparison of an indirect fluorescent antibody test for detection of antibodies to Sarcocystis neurona, using serum and cerebrospinal fluid of naturally and experimentally infected, and vaccinated horses. J Parasitol 90 (2004) 379-386
91. Saville W.J., Dubey J.P., Oglesbee M.J., et al. Experimental infection of ponies with Sarcocystis fayeri and differentiation from Sarcocystis neurona infections in horses. J Parasitol 90 (2004) 1487-1491
92. Hoane J.S., Morrow J.K., Saville W.J., et al. Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens. Clin Diagn Lab Immunol 12 (2005) 1050-1056
93. Cook A.G., Buechner-Maxwell V., Morrow J.K., et al. Interpretation of the detection of Sarcocystis neurona antibodies in the serum of young horses. Vet Parasitol 95 (2001) 187-195
94. Cook A.G., Buechner-Maxwell V., Donaldson L.L., et al. Detection of antibodies against Sarcocystis neurona in cerebrospinal fluid from clinically normal neonatal foals. J Am Vet Med Assoc 220 (2002) 208-211
95. Gray L.C., Magdesian K.G., Sturges B.K., et al. Suspected protozoal myeloencephalitis in a two-month-old colt. Vet Rec 149 (2001) 269-273
96. Duarte P.C., Conrad P.A., Barr B.C., et al. Risk of transplacental transmission of Sarcocystis neurona and Neospora hughesi in California horses. J Parasitol 90 (2004) 1345-1351
97. Duarte P.C., Conrad P.A., Wilson W.D., et al. Risk of postnatal exposure to Sarcocystis neurona and Neospora hughesi in horses. Am J Vet Res 65 (2004) 1047-1052
98. Marsh A.E., Lakritz J., Johnson P.J., et al. Evaluation of immune responses in horses immunized using a killed Sarcocystis neurona vaccine. Vet Ther 5 (2004) 34-42
99. Rossano M.G., Schott III H.C., Kaneene J.B., et al. Effect of daily administration of pyrantel tartrate in preventing infection in horses experimentally challenged with Sarcocystis neurona. J Am Vet Med Assoc 66 (2005) 846-852
100. Henninger R. Epidemic neurologic disease due to equine herpesvirus 1: the University of Findlay English Equestrian Center. In: Proceedings of the Ninth International Veterinary Emergency and Critical Care Symposium. New Orleans (LA); 2003. p. 621-4.
101. Reed S., and Toribio R. Equine herpes virus 1 and 4. Vet Clin North Am Equine Pract 20 (2004) 631-642
102. Friday P., Scarratt W., Elvinger F., et al. Ataxia and paresis with equine herpes type 1 infection in a herd of riding school horses. J Vet Intern Med 14 (2000) 197-201
103. Van Maanen C., Sloet van Oldruitenborgh-Oosterbaan M.M., Damen E.A., et al. Neurological disease associated with EHV-1 infection in a riding school: clinical and virological characteristics. Equine Vet J 33 (2001) 191-196
104. Studdert M.J., Hartley C.A., Dynon K., et al. Outbreak of equine herpesvirus type 1 myeloencephalitis: new insights from virus identification by PCR and the application of an EHV-1-specific antibody detection ELISA. Vet Rec 153 (2003) 417-423
105. Ostlund E.N. The equine herpesviruses. Vet Clin North Am Equine Pract 9 (1993) 283-294
106. Wilson W.D. Equine herpesvirus 1 myeloencephalopathy. Vet Clin North Am Equine Pract 13 (1997) 53-72
107. O'Callaghan D.J., and Osterrieder N. Equine herpes viruses. In: Webster R.G., and Granoff A. (Eds). Encyclopedia of virology (1999), Harcourt Brace & Company, San Diego (CA) 508-515
108. Patel J.R., Edington N., and Mumford J.A. Variation in cellular tropism between isolates of equine herpes virus-1 in foals. Arch Virol 7 (1982) 41-51
109. Allen G. New insights into equine herpesvirus-1 (EHV-1) neurological disease. Equine Dis Q 200;15(1):2-3.
110. Allen G.P., and Breathnach C.C. Quantification by real-time PCR of the magnitude and duration of leukocyte-associated viraemia in horses infected with neuropathogenic versus non-neuropathogenic strains of Equid herpesvirus-1. Equine Vet J 38 (2006) 252-257
111. Donaldson M.T., and Sweeney C.R. Equine herpes myeloencephalopathy. Compend Contin Educ Pract Vet 19 (1997) 864-871
112. Donaldson M.T., and Sweeney C.R. Herpesvirus myeloencephalopathy in horses: 11 cases (1982-1996). J Am Vet Med Assoc 213 (1998) 671-675
113. McCartan C.G., Russell M.M., Wood J.L., et al. Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. Vet Rec 136 (1995) 7-12
114. Crabb B.S., and Studdert M.J. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host. J Virol 67 (1993) 6332-6338
115. Allen G.P. Epidemic disease caused by Equine herpesvirus-1: recommendations for prevention and control. Equine Vet Educ 14 (2002) 136-142
116. Yasunaga S., Maeda K., Matsumura T., et al. Diagnosis and sero-epizootiology of equine herpesvirus type 1 and type 4 infections in Japan using a type-specific ELISA. J Vet Med Sci 60 (1998) 1133-1137
117. Yasunaga S., Maeda K., Matsumura T., et al. Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine. J Vet Med Sci 62 (2000) 687-691
118. Singh B.K., Ahuja S., and Gulati B.R. Development of a neutralizing monoclonal antibody-based blocking ELISA for detection of equine herpesvirus 1 antibodies. Vet Res Commun 28 (2004) 437-446
119. Smith D.J., Iqbal J., Purewal A., et al. In vitro reactivation of latent equid herpesvirus-1 from CD5+/CD8+ leukocytes indirectly by IL-2 or chorionic gonadotrophin. J Gen Virol 79 (1998) 2997-3004
120. Mumford J.A. The development of diagnostic techniques for equine viral diseases. Vet Ann 24 (1984) 182-189
121. Patel J.R., and Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)-epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170 (2005) 14-23
122. Carvalho R., Passos L.M., and Martins A.S. Development of a differential multiplex PCR assay for equine herpesvirus 1 and 4 as a diagnostic tool. J Vet Med B Infect Dis Vet Public Health 47 (2000) 351-359
123. Lawrence G.L., Gilkerson J., Love D.N., et al. Rapid, single-step differentiation of equid herpesviruses 1 and 4 from clinical material using the polymerase chain reaction and virus-specific primers. J Virol Methods 47 (1994) 59-72
124. Daly P., and Doyle S. The development of a competitive PCR-ELISA for the detection of equine herpesvirus-1. J Virol Methods 107 (2003) 237-244
125. Varrasso A., Dynon K., Ficorilli N., et al. Identification of equine herpesviruses 1 and 4 by polymerase chain reaction. Aust Vet J 79 (2001) 563-569
126. Pusterla N, Leutenegger CM, Wilson WD, et al. Equine herpesvirus 4 infection in foals: quantitation of viral DNA in nasal secretions and peripheral blood leukocytes during an outbreak using the real-time Taqman® PCR. In: Proceedings of the 21st Annual American College of Veterinary Internal Medicine Forum. Charlotte (NC); 2003. p. 33.
127. Goehring LS. Equine herpes virus type 1 myeloencephalopathy: a quantitative approach. In: Proceedings of the 22nd Annual American College of Veterinary Internal Medicine Forum. Minneapolis (MN); 2004. p. 168-9.
128. Pronost S, Gouarin S, Leon A, et al. The development of a real time PCR assay for differentiation of EHV-1 infection or latent states in tissues. In: Proceedings of the 11th Societa Italiana Veterinari per Equini National Congress. Pisa (Italy); 2005. p. 204.
129. Allen GP. Antemortem detection of horses latently infected with neuropathogenic strains of equine herpesvirus-1. Am J Vet Res 2006, accepted for publication.
130. Nugent J., Birch-Machin I., Smith K.C., et al. Analysis of equine herpes-virus type 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus non-neuropathogenic disease outbreaks. J Virol 80 (2006) 4047-4060
131. Bryans J.T., and Allen G.P. Herpesviral diseases of the horse. In: Wittmann G. (Ed). Herpesviral diseases of cattle, horses and pigs (1989), Kluwer, Boston (MA) 176-229
132. Whitwell K.E., and Blunden A.S. Pathological findings in horses dying during an outbreak of the paralytic form of Equid herpesvirus type 1 (EHV-1) infection. Equine Vet J 24 (1992) 13-19
133. Platt H., Singh H., and Whitwell K.E. Pathological observations on an outbreak of paralysis in broodmares. Equine Vet J 12 (1980) 118-126
134. Slater J.D., Borchers K., Thackery A.M., et al. The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol 75 (1994) 2007-2016
135. Collins P. The spectrum of antiviral activities of acyclovir in vitro and in vivo. J Antimicrob Chemother 12 (1983) 19-27
136. Schaeffer H.J. Acyclovir chemistry and spectrum of activity. Am J Med 73 (1982) 4-6
137. Wilkins PA. Controversies in EHV-1 myeloencephalopathy. In: Proceedings of the Ninth International Veterinary Emergency and Critical Care Symposium. New Orleans (LA); 2003. p. 669-70.
138. Collins P. The spectrum of antiviral activities of acyclovir in vitro and in vivo. J Antimicrob Chemother 12 (1983) 19-27
139. Rollinson E.A., and White G. Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses. Antimicrob Agents Chemother 24 (1983) 221-226
140. Wilkins PA, Del Piero F, de Lahunta A, et al. Paralytic equine herpes virus: 1978-1997. In: Proceedings of the Eighth International Conference on Equine Infectious Diseases. Dubai (United Arab Emirates); 1998. p. 596-7.
141. Friday P.A., Scarratt W.K., Elvinger F., et al. Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses. J Vet Intern Med 14 (2000) 197-201
142. Wilkins PA, Henninger R, Reed SM, et al. Acyclovir as treatment for EHV-1 myeloencephalopathy. In: Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners. New Orleans (LA); 2003. p. 394-6.
143. Wikins P, Papich M, Sweeney RW. Acyclovir pharmacokinetics in the horse. In: Proceedings of the American College of Veterinary Internal Medicine Forum. Baltimore (MD); 2005. p. 945.
144. Bentz BG, Maxwell LK, Clarke CR, et al. The pharmacokinetics of acyclovir in adult horses following single intravenous and intragastric dosing. In: Proceedings of the American College of Veterinary Internal Medicine Forum. Baltimore (MD); 2005. p. 945-6.
145. de la Fuente R., Awan A.R., and Field H.J. The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model. Antiviral Res 18 (1992) 77-89
146. Smith K.O., Galloway K.S., Hodges S.L., et al. Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine. Am J Vet Res 44 (1983) 1032-1035
147. Heldens J.G.M., Hannant D., Cullinane A.A., et al. Clinical evaluation of the efficacy of an inactivated EH-1 and EH-4 whole virus vaccine (Duvaxyn EHV1, 4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19 (2001) 4307-4317
148. Slater J., and Hannant D. Equine immunity to viruses. Vet Clin North Am Equine Pract 16 (2000) 49-68
149. Mumford JA, Hannant DA, Jessett DM, et al. Abortigenic and neurological disease caused by infection with equid herpesvirus-1. In: Proceedings of the Seventh International Conference of Equine Infectious Diseases. Newmarket (England); 1995. p. 261-75.
150. Kydd J.H., Wattrang E., and Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific cytotoxic lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 96 (2003) 207-217
151. Kaashoek M.J., Moerman A., Madic J., et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12 (1994) 439-444
152. Mettenleiter T.C., Klupp B.G., Weiland F., et al. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. J Gen Virol 75 (1994) 1723-1733
153. Matsumura T., O'Callaghan D.J., Kondo T., et al. Lack of virulence of the murine fibroblast adopted strain, Kentucky A (KyA) of equine herpesvirus type 1 (EHV-1) in young horses. Vet Microbiol 48 (1996) 353-365
154. Cornick J., Martens J., Crandell R., et al. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Can J Vet Res 54 (1990) 260-266
155. Matsumara T., Kondo T., Sugita S., et al. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology 242 (1998) 68-79
156. Rappocciolo G., Birch J., and Ellis S.A. Down-regulation of MHC class 1 expression by equine herpesvirus-1. J Gen Virol 84 (2003) 293-300
157. Spear P. Glycoproteins specified by herpes simplex virus. In: Roizman B. (Ed). The herpesviruses (1984), Plenum Press, New York 315-356
158. Foote C.E., Love D.N., Gilkerson J.R., et al. Serum antibody responses to equine herpes virus 1 glycoprotein D in horses, pregnant mares and young foals. Vet Immunol Immunopathol 105 (2005) 47-57
159. Patel J.R., Bateman H., Williams J., et al. Derivation and characterisation of a live equid herpesvirus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Vet Microbiol 91 (2003) 23-39
160. Patel J.R., Foldi J., Bateman H., et al. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Vet Microbiol 92 (2003) 1-17
161. Patel J.R., Didlick S., and Bateman H. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally derived antibody. Protection against EHV-1 infection. Equine Vet J 36 (2004) 447-451
162. Gilkerson J.R., Love D.N., and Whalley J.M. Incidence of equine herpesvirus 1 infection in Thoroughbred weanlings on two stud farms. Aust Vet J 78 (2000) 277-278
163. Gilkerson J.R., Whalley J.M., Drummer H.E., et al. Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997. Vet Microbiol 68 (1999) 15-25
164. Gilkerson J.R., Whalley J.M., Drummer H.E., et al. Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals. Vet Microbiol 68 (1999) 27-34
165. Foote C.E., Love D.N., Gilkerson J.R., et al. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus-1 and equine herpesvirus 4 vaccine. Vet Microbiol 88 (2002) 13-25
166. Wilson W, Rossdale PD. Effect of age on the serological responses of Thoroughbred foals to vaccination with an inactivated EHV-1/EHV-4 vaccine. In: Proceedings of the Eighth International Conference on Equine Infectious Diseases. Newmarket (England); 1999. p. 428.
167. Breathnach CC, Allen GP, Holland RE, et al. Problems associated with vaccination of foals against equine herpesvirus-4 and the role of EHV-4 maternal antibodies. In: Proceedings of the Eighth International Conference on Equine Infectious Diseases. Newmarket (England); 1999. p. 418-9.
168. Castillo-Olivares J., and Wood J. West Nile virus infection of horses. Vet Res 35 (2004) 467-483
169. Ostlund E.N., Andresen J.E., and Andresen M. West Nile encephalitis. Vet Clin North Am Equine Pract 16 (2000) 427-441
170. Long MT, Porter MB. West Nile virus-clinical presentation, differentiation from other encephalitides, and management. In: Proceedings of the 20th Annual American College of Veterinary Internal Medicine Forum. Dallas (TX); 2002. p. 151-3.
171. Ward M.P., Levy M., Thacker H.L., et al. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses. J Am Vet Med Assoc 225 (2004) 84-89
172. Porter M.B., Long M.T., Getman L.M., et al. West Nile Virus encephalomyelitis in horses: 46 cases (2001). J Am Vet Med Assoc 222 (2003) 1241-1247
173. Snook C.S., Hyman S.S., Del Piero F., et al. West Nile virus encephalomyelitis in eight horses. J Am Vet Med Assoc 218 (2001) 1576-1579
174. Schuler L.A., Khaitsa M.L., Dyer N.W., et al. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J Am Vet Med Assoc 225 (2004) 1084-1088
175. Wamsley H.L., Alleman A.R., Porter M.B., et al. Findings in cerebrospinal fluids of horses infected with West Nile virus: 30 cases (2001). J Am Vet Med Assoc 221 (2002) 1303-1305
176. Davidson A.H., Traub-Dargatz J.L., Rodeheaver R.M., et al. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J Am Vet Med Assoc 226 (2005) 240-245
177. Ostlund E.N., Crom R.L., Pederson D.D., et al. Equine West Nile encephalitis, United States. Emerg Infect Dis 7 (2001) 665-669
178. Porter M.B., Long M., Gosche D.G., et al. Immunoglobulin M-capture enzyme-linked immunosorbent assay testing of cerebrospinal fluid and serum from horses exposed to West Nile virus by vaccination or natural infection. J Vet Intern Med 18 (2004) 866-870
179. Wang T., Magnarelli L.A., Anderson J.F., et al. A recombinant envelope protein-based enzyme-linked immunosorbent assay for West Nile virus serodiagnosis. Vector Borne Zoonotic Dis 2 (2002) 105-109
180. Kleiboeker S.B., Loiacono C.M., Rottinghaus A., et al. Diagnosis of west Nile virus infection in horses. J Vet Diagn Invest 16 (2004) 2-10
181. Long MT, Ostlund EN, Porter MB, et al. Equine West Nile encephalitis: epidemiological and clinical review for practitioners. In: Proceedings of the 48th American Association of Equine Practitioners. Orlando (FL); 2002. p. 1-6.
182. st century. J Vet Emerg Crit Care 14 (2004) 2-14
183. Salazar P., Traub-Dargatz J.L., Morley P.S., et al. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J Am Vet Med Assoc 225 (2004) 267-274
184. Pyrgos V., and Younus F. High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand J Infect Dis 36 (2004) 509-512
185. Jackson A.C. Therapy of West Nile virus infection. Can J Neurol Sci 31 (2004) 131-134
186. Ben-Nathan D., Lustig S., Tam G., et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 188 (2003) 5-12
187. Julander J.G., Winger Q.A., Olsen A.L., et al. Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. Antiviral Res 65 (2005) 79-85
188. Engle M.J., and Diamond M.S. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol 77 (2003) 12941-12949
189. Ng T., Hathaway D., Jennings N., et al. Equine vaccine for West Nile virus. Dev Biol (Basel) 114 (2003) 221-227
190. Vest D.J., Cohen N.D., Berezoski C.J., et al. Evaluation of administration of West Nile virus vaccine to pregnant broodmares. J Am Vet Med Assoc 225 (2004) 1894-1897
191. Minke J.M., Siger L., Karaca K., et al. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch Virol Suppl 18 (2004) 221-230
192. Siger L., Bowen R.A., Karaca K., et al. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to a natural challenge with West Nile virus-infected mosquitoes in horses. Am J Vet Res 65 (2004) 1459-1462
193. Grosenbaugh D.A., Backus C.S., Karaca K., et al. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine. Vet Ther 5 (2004) 251-257